Research programme: FASN inhibitors - 3-V Biosciences

Drug Profile

Research programme: FASN inhibitors - 3-V Biosciences

Alternative Names: TVB-3664

Latest Information Update: 21 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator 3-V Biosciences
  • Class Small molecules
  • Mechanism of Action Fatty acid synthetase complex inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Cytomegalovirus infections; Non-alcoholic steatohepatitis; Parainfluenza virus infections; Solid tumours
  • No development reported Hepatitis C; Herpes simplex virus infections; Respiratory syncytial virus infections

Most Recent Events

  • 20 Oct 2017 Pharmacodynamics data from a preclinical trial in non-alcoholic steatohepatitis presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2017)
  • 16 Oct 2017 Preclinical trials in Non-alcoholic steatohepatitis in USA (PO)
  • 01 Apr 2017 Pharmacodynamics data from preclinical studies in Solid tumours presented at the 108th Annual Meeting of the American Association for Cancer Research (AACR-2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top